CO-DIRECTOR, THE KELLY G. RIPKEN PROGRAM
DIRECTOR, THE KELLY & CAL RIPKEN, JR. FOUNDATION
Mrs. Ripken, 38, co-founded The Kelly & Cal Ripken, Jr. Foundation and serves as a director. She is an active supporter of the Baltimore School for the Arts and the Johns Hopkins Children's Center. Mrs. Ripken was instrumental in establishing the Baltimore Reads Ripken Learning Center and serves on the Board of Directors of Baltimore Reads, Inc. She has been a spokesperson for education and family literacy, fitness and healthy living, the American Autoimmune Related Diseases Association, the American Lung Association and Maryland State Parks.
She and her husband, Cal Ripken, Jr., have two children.
|Paul Ladenson, M.D.
Dr. Ladenson, an expert on thyroid disorders and thyroid cancers, is the John Eager Howard Professor of Medicine at Hopkins and professor of pathology, oncology and international health. He is also co-director of The Johns Hopkins Endocrine Cost-Effectiveness Study Unit. Dr. Ladenson's principal research interests have been the cost-effectiveness of thyroid disease management, cardiovascular effects of thyroid hormone, and thyroid cancer. He recently was lead author of a national study in the New England Journal of Medicine showing that a genetically engineered thyroid-stimulating compound -- recombinant human thyroid-stimulating hormone (rhTSH) -- could be used safely and effectively to screen for recurrence of thyroid cancer after surgery.
Dr. Ladenson is president of the Association of Program Directors in Endocrinology and Metabolism and serves on the board of directors of the Thyroid Foundation of America, Maryland Affiliate. He also is director of the Association of Subspecialty Professors, representing program directors in endocrinology and metabolism. He joined the Hopkins faculty in 1983.